ATS 2019 Virtual Final Program

formal and informal caregiving has grown tremendously. Approximately 43.5 million American caregivers provided unpaid care to an adult or child. The international burden is even greater. Adults over the age of 80-who have a high likelihood of physical and cognitive impairments and great need of caregiving services represent the fastest growing population of older adults. As a result, the need for caregiving is only expected to increase as our society ages. It isn’t only older adults who may need caregiving services, 7% of children have multiple chronic conditions that could require caregiving services. This symposium will discuss the emerging issues and consequences of caregiver burden, and will review potential interventions that may reduce the problem. Chairing: M. Moss, MD, ATSF, Aurora, CO K. Connolly, BS, Danvers, MA 9:15 PAR Awards Presentation K. Connolly, BS, Danvers, MA 9:25 A Patient’s Perspective S. Burlile, PhD, Meridian, ID 9:35 Caregiver Burden: What Is It and Why Is It Important B.A. Graney, MD, Aurora, CO 9:55 Helpful and Unhelpful Behaviors of Caregivers in Supporting Disease Management K.J. Haines, PhD, BHS, Melbourne, Australia 10:15 Caregiver Burden in Health Care Professionals M. Mealer, PhD, Denver, CO 10:35 How to Alleviate Caregiver Burden: Potential Interventions M.S. Herridge, MD, Toronto, Canada 10:55 The Future of Caregiver Burden Research L. Saketkoo, MD, MPH, New Orleans, LA CLINICAL SCIENTIFIC SYMPOSIUM CME Credits Available: 2 MOC Points Available: 2 A13 STATE OF THE ART TREATMENT OF TOBACCO DEPENDENCE Tobacco Action Committee; Assemblies on Behavioral Science and Health Services Research; Thoracic Oncology 9:15 a.m. - 11:15 a.m. KBHCCD Room D167/D174 (Level 1) Target Audience Interprofessional (physicians, nurses, allied health, in training) clinicians who care for patients with tobacco dependence and/or treat their tobacco related disease. Researchers with an interest in tobacco dependence biology and treatment Objectives At the conclusion of this session, the participant will be able to: • learn evidence based recommendations for pharamacotherapy treatment for tobacco dependence; • discuss potential barriers to tobacco dependence treatment including e-cigarettes and flavorings; • acquire new strategies and tools to integrate tobacco dependence treatment into novel care setting to target health disparities. Tobacco dependence is the leading cause of lung disease in the U.S. and internationally and has significant disparities without most vulnerable populations at greatest risk. Our understanding of the most effective strategies for treatment of tobacco dependence has improved in recent years. This session seeks to improve the treatment of tobacco dependence by providing evidence-based recommendations for interventions that have been proven to improve clinical outcomes as well as discuss potential barriers to treatment including electronic cigarettes and flavorings. The session will also include novel methods for integrating tobacco dependence treatment into different care settings to reduce known disparities. Chairing: M. Eakin, PhD, Baltimore, MD H. Kathuria, MD, ATSF, Boston, MA H.J. Farber, MD, MSPH, ATSF, Houston, TX 9:15 Pharmacological Treatment of Tobacco Dependence F.T. Leone, MD, MS, ATSF, Philadelphia, PA 9:35 They Did Not Stop Tobacco After 6 Weeks! The Evidence Behind Extended Treatment of Tobacco Dependence D.P.I. Sachs, MD, Palo Alto, CA 9:55 Menthol Makes it Smooth: The Use of Flavorings to Promote Tobacco Use E.R. Neptune, MD, Baltimore, MD 10:10 More of a Foe Than Friend: The Role of E-Cigarettes in Tobacco Dependence Treatment I. Jaspers, PhD, Chapel Hill, NC 10:30 Tobacco Dependence Treatment for the Marginalized Populations S. Pakhale, MD, MSCE, Ottawa, Canada 10:45 Do It for the Kids? Treating Parents for Tobacco Dependence in Pediatric Settings T.J. Moraes, MD, Toronto, Canada 11:00 Teachable Moment: Integrating Tobacco Dependence Treatment into the Inpatient Setting H. Kathuria, MD, ATSF, Boston, MA CLINICAL MINI SYMPOSIUM A14 REDUCING DISPARITIES AND IMPROVING OUTCOMES OF LUNG CANCER SCREENING 9:15 a.m. - 11:15 a.m. KBHCCD Ballroom A One (Level 2) Chairing: C.G. Slatore, MD, Portland, OR J. Iaccarino, MD, MSc, Boston, MA A.C. Melzer, MD, MS, Minneapolis, MN Oral Presentations 9:15 Racial Differences in Attitudes Toward Lung Cancer Screening/ M. Lake, M. Pimpinelli, B. Ruane, T. Giamboy, M. Unger, N. Evans, G.C. Kane, R. McIntire, H.-S. Juon, J. Barta, Philadelphia, PA, p.A1001 ATS 2019 • Dallas, TX SUNDAY • MAY 19 31 SUNDAY MORNING